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Background: Tubo-ovarian abscesses are entities of infectious etiology, mostly as a result of pelvic in-
ﬂammatory disease. Over the past decades we veriﬁed that the treatment is lifesaving and the approach
can be, and should be, minimally invasive. The advent of antibiotics, its parenteral combined adminis-
tration, and the appearance of techniques of drainage, made possible a better treatment of this patho-
logical condition.
Objective: Analysis of our experience in tubo-ovarian abscess treatment.
Methods: Retrospective study, with database consultation, of all cases of tubo-ovarian abscesses treated
in our department during a period of 4 years (2009e2012), with emphasis on our experience using a
minimally invasive surgical approach, performed in 22 cases.
Results: Forty-ﬁve cases medically and surgically treated, with 17 cases undergoing a drainage
procedure.
Conclusion: A minimally invasive procedure was performed in almost half of the cases with a faster
clinical improvement and low morbidity.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Tubo-ovarian abscess (TOA) is a consequence of an infectious
process with collected pus involving adnexa. The infection is, in the
majority of cases, polymicrobial, composed of anaerobic and gram-
negative bacteria, that ascends to the pelvic space. TOA occurs in
the context of pelvic inﬂammatory disease (PID) in about 30% of
cases,1 being classiﬁed as primary, or secondary when occurs as a
consequence of other intra-abdominal processes.1
The diagnosis of TOA is made by clinical, laboratory, and imaging
aspects. In the clinic evaluation, the more consistent symptom is
abdominal pain (pelvic pain) and the principal sign is uterine
tenderness; in laboratory studies the most important ﬁndings are
elevation of white blood cells and inﬂammatory markers (C-reac-
tive protein). The gold standard examination for the diagnosis of
TOA is ultrasonography, mainly when executed with a vaginal
transducer. The visualization of a complex cystic neoformation in
the pelvic compartment, with heterogeneous compound and withnd Obstetrician, Centro Hos-
e n 380, 3 esquerdo, 4430-
).
for Gynecologic Endoscopy and Minimhigh resistance index in Doppler studies, is very suggestive of
abscess.1,2
In the past, the existence of an abdominal or pelvic abscess was a
cause ofmortality and the treatment was synonymouswith surgery
using a laparotomy approach. Currently, the treatment of TOA ob-
ligates to hospitalization for the introduction of parenteral com-
bined ample spectrum antibiotherapy. The early diagnosis and the
advent of these therapies permitted medical treatment success
in about 70e75% of cases.2 The others 25e30% of cases requires
surgical drainage, which can be performed using minimally inva-
sive surgical approaches, such as laparoscopic drainage or trans-
vaginal punction and drainage with ultrasonographic control, this
one considered the gold standard.3,4
The change in the management of TOA inspired us to perform a
casuistic analysis of our department experience over a 4-year
period (2009e2012).Objectives and Methodology
This is a retrospective study, through database consultation, of
all cases of TOA attending the Gynecology Department of Centro
Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugalally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
History and sociodemographic characteristics of study population.
Sociodemographic characteristics N
Age (y)
23e29 4
30e39 16
40e49 14
50e59 10
 60 1
Race
White 44
Black 1
Other 0
Reproductive history
Gravidity
0 5
1e2 25
 3 15
Parity
0 5
1e2 33
 3 7
Contraception
Menopause 6
None 3
Hysterectomy 1
Condom use 4
Tubal ligation 6
Intrauterine device 19 (no *)
Oral contraceptives 1
Figure 2. Contraceptive methods in 30 cases. B ¼ barrier; IUD ¼ intra uterine device;
OC ¼ oral contraception; TL ¼ tubal ligation.
Table 2
Clinical characteristics by presence of tubo-ovarian abscess.
Clinical characteristics N
Symptoms
Pelvic pain 45
Median duration of pain 6 days
Abnormal bleeding 8
Cervical discharge 20
Signs
Fever 24
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analysis of clinical presentation, management, and therapeutic re-
sults was performed.
All cases of TOA were treated with ample spectrum parenteral
antibiotic therapy (1st line: gentamicin, 1.5 mg/kg every 8 hours,
plus clindamycin, 900 mg every 8 hours). The surgical approach
was applied in rupture (urgent procedure), or in TOA persistence. In
some cases a minimally invasive procedure, transvaginal
ultrasound-guided drainage, and sclerosis, were combinedwith the
medical treatment or performed with TOA persistence, in women
without signs of acute abdomen/peritonitis and clinically stable.
In cases with surgical indication, (signs of peritonitis or TOA
persistence), laparotomy and laparoscopy were performed, with
different associated procedures according to patient age and sur-
gical ﬁndings: abscess drainage, salpingectomy (unilateral or
bilateral), anexectomy (unilateral or bilateral), and hysterectomy.
Results
In the referred period 45 cases of TOA were admitted and
treated in our center.
All cases started medical treatment immediately after hospi-
talization, with ample spectrum antibiotic association.
The average age of our population was 41, 9 years old (23e72
years). We veriﬁed the existence of other pathologies or medical
conditions in 25 cases (Figure 1); 40 women were in reproductive
age, 28ofwhomwereusing contraception (Table 1); 30womenused
some contraceptive method, of them an intrauterine device (IUD)
wasused in 19 cases (2 cases inwomen inpostmenopause; Figure 2).
Previous surgery before 1 month in two cases (appendectomy
and abdominal hysterectomy) and a postpartum period in one case
(vaginal delivery).
Complementary examinations were performed in all cases with
analytic and ultrasound study, with the appearance of a pelvic
neoformation, heterogeneous and with high resistance ﬂuxometry,
suggestive of TOA (Table 2 and Figures 3 and 4).
Medical treatment was performed in all cases with combined
clindamycin and gentamicin in 27 cases, clindamycin, gentamicin,
and penicillin in 14 cases, and clindamycin, gentamicin, and
metronidazole in four cases.
Surgical drainage was realized in the 45 cases (100%); the
average days of previous medical treatment was 1,9 (0e13) days.
The surgical procedures are described in Table 3.
The drainage procedure, ultrasound guided, was held in 17
cases. All of these abscesses were primary, with no response to
medical treatment in an average of 3 days. The procedure occurred
without immediate complications, with need for more than one
drainage in two cases and a laparoscopy procedure in another two
cases, due to abscess persistence.Figure 1. Comorbidities in 25/45 cases. Others ¼ severe endometriosis, depression and
respiratory disease.
Cervical discharge 26
Uterine tenderness 42
Complementary examinations
WBC (mean) 15,3
WBC
< 10 6
10e15 8
> 15 31
CRP elevated 37
CT performed 9
US performed 45
Unilateral abscess 37
Bilateral abscess 8
Largest abscess size (mean) (range ¼ 1.6e10.2 cm)
0e4 cm 5
5e8 cm 24
> 8 cm 16
CRP ¼ C-reactive protein; CT ¼ Computed tomography;
US ¼ ultrasonography; WBC ¼ white blood cells.
Figure 3. Heterogeneous pelvic neoformation.
Figure 4. Periferic vascularization of high resistance.
Table 3
Surgical procedures realized (n ¼ 45).
Laparotomy Laparoscopy Transvaginal puncture and aspirative drainage
23a 7b 17
a One case needed a puncture procedure 3 days after.
b Two cases done after a puncture procedure.
Figure 5. Microbiologic results.
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procedure, 8 of 10 after laparotomy (Table 4). The average days of
hospitalization by procedure were: 12 days in laparotomy, 6 days in
transvaginal puncture with aspirative drainage and 5 days in
laparoscopy.
A microbiology result was possible in 33 of 45 cases and the
most frequent isolated agent was Escherichia coli (Figure 5). The
infection was polymicrobian in 10 cases and in seven cases there
was no growth.Table 4
Complications after surgery.
Complications N Proced
Wound infection 2 Laparo
Vaginal vault hematoma 1 Laparo
Wound dehiscence 2 Laparo
Faecal peritonitis 1 Laparo
Maintenance abdominal masses 1 Laparo
Persistence of pelvic abscess 1 Laparo
Persistence of pelvic abscess 2 VaginDiscussion
This small casuistic showa populationwith average age superior
to that described in literature. Although the IUD is not considered a
risk factor to PID, only within the ﬁrst 3 weeks after insertion,2 it
was the most used contraceptive method in this population. Risk
factors for TOA were identiﬁed in three cases and were related to
recent pelvic surgery and postpartum period.
The 45 patients admitted to our center had TOA that were
mostly a consequence of PID (41 primary abscesses), and secondary
to other pelvic conditions in four cases (after acute appendicitis;
associated with a rectal cancer; associated with an ovarian complex
cyst and after laparoscopic cholecystectomy). All cases were
medically treated with combined antibiotherapy, in majority of
cases with clindamycin and gentamycin association. In IUD carriers,
penicillin was added due to higher risk of Actinomyces infection.
The need for surgical drainagewas universal to all cases, and this
was the greatest difference relative to published statistics. A
minimally invasive procedure was performed in 22 of 45 cases
(48.8%), by laparoscopy approach and transvaginal ultrasound-
guided drainage and sclerosis, without complications and with
less morbidity and hospitalization time.
According to data drainage procedures, an ultrasound-guided
procedure may be a ﬁrst-line procedure for the treatment of TOA,
in a stable patient without peritonitis.4e6 Although the medical
treatment can be successful, an earlier intervention with this
technique can improve the results and minimize morbidity, hos-
pitalization time, and costs. The complications reported in our
study were mostly in patients who underwent laparotomy, in this
group with important morbidity and hospitalization time. Our
experience, despite the small number of cases, also supports that
TOA should be treated with a drainage procedure, ultrasound-
guided, a simple and safe intervention.ure performed Treatment
tomy Medical (ATB)
tomy Digital permeabilization
tomy Surgical correction
tomy Re-laparotomy (Ca rectum)
tomy Re-laparotomy (partial enterectomy)
tomy Aspirative drainage
al aspirative punction Laparosocpy
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